Paolo Fiorina, MD, PhD is an endocrinologist. He is Director, International Center for T1D, Romeo ed Enrica Invernizzi Pediatric, University of Milan, Italy; Professor of Endocrinology, L. Sacco Hospital, University of Milan; Chief of Division of Endocrinology, ASST Sacco-Fatebenefratelli, Milan, Italy and Lecturer on Pediatrics, Boston Children’s Hospital, Harvard Medical School. He is actively involved in the Grant Committee of JDRF, Medical Science Review Committee (MSRC) for Islet Biology and Transplantation, Transplant Meeting Committee at the San Raffaele Hospital (Milan), American Heart Association (AHA), and American Society of Transplantation (AST).

He published over 140 peer-reviewed manuscripts (5700+ citations, h-index 44). He is focused in devising new immune-based preventive and therapeutic strategies for autoimmune diseases.

His publication track record includes seminal contribution to the field of immunotherapy for the treatment of type 1 diabetes and of transplantation and stem cells to prevent and treat autoimmune diabetes and allograft rejection.

No Comments

Sorry, the comment form is closed at this time.